» Articles » PMID: 23686293

Low-grade (WHO II) and Anaplastic (WHO III) Gliomas: Differences in Morphology and MRI Signal Intensities

Overview
Journal Eur Radiol
Specialty Radiology
Date 2013 May 21
PMID 23686293
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the diagnostic potential of a multi-factor analysis of morphometric parameters and signal characteristics of brain tumours and peritumoural areas for distinguishing WHO-grade II and III gliomas at magnetic resonance imaging (MRI).

Methods: MR examinations of 108 patients with histologically proven World Health Organization (WHO) grade II and III gliomas were included. Morphological criteria and MR signal characteristics were evaluated. The data were subjected to a multifactorial logistic regression analysis to differentiate between grade II and grade III gliomas. The discriminatory power was assessed by receiver operating characteristic (ROC).

Results: Logistic regression analysis showed that WHO grade II and III can be distinguished based on contrast enhancement, cortical involvement, margin of the enhancing lesion and maximum diameter (width and length) of the peritumoural area (the so-called tumour infiltration zone). With the final model of logistic regression analysis and with the cut-off value  ≥  0.377, WHO grade III glioma is predicted with a sensitivity of 71.0 % and a specificity of 80.4 %.

Conclusion: Measurement of maximum diameter of peritumoural area, contrast enhancement as well as cortical involvement and the margin of the contrast-enhancing lesion can be used easily in clinical routine to adequately distinguish WHO grade II from grade III gliomas.

Key Points: • MRI offers new information concerning WHO-grade II and III gliomas. • The differentiation between such tumour grades is important for therapeutic decisions. • We assessed differences in enhancement, cortical involvement, margins and peritumoural appearances. • WHO grade III gliomas can be predicted with reasonable sensitivity and specificity.

Citing Articles

Evaluation of glial tumors: correlation between magnetic resonance imaging and histopathological analysis.

Campos L, de Oliveira F, Antunes A, Duarte J Radiol Bras. 2024; 57:e20240025.

PMID: 39290827 PMC: 11406976. DOI: 10.1590/0100-3984.2024.0025.


5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches.

Kiesel B, Freund J, Reichert D, Wadiura L, Erkkilae M, Woehrer A Front Oncol. 2021; 11:699301.

PMID: 34395266 PMC: 8362830. DOI: 10.3389/fonc.2021.699301.


5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers.

Hosmann A, Millesi M, Wadiura L, Kiesel B, Mercea P, Mischkulnig M Cancers (Basel). 2021; 13(11).

PMID: 34064222 PMC: 8196836. DOI: 10.3390/cancers13112540.


T2 mapping of molecular subtypes of WHO grade II/III gliomas.

Kern M, Auer T, Picht T, Misch M, Wiener E BMC Neurol. 2020; 20(1):8.

PMID: 31914945 PMC: 6947951. DOI: 10.1186/s12883-019-1590-1.


Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age.

Castet F, Alanya E, Vidal N, Izquierdo C, Mesia C, Ducray F J Neurooncol. 2019; 143(3):515-523.

PMID: 31054099 DOI: 10.1007/s11060-019-03183-2.


References
1.
Mills S, Soh C, OConnor J, Rose C, Buonaccorsi G, Cheung S . Tumour enhancing fraction (EnF) in glioma: relationship to tumour grade. Eur Radiol. 2009; 19(6):1489-98. DOI: 10.1007/s00330-008-1288-z. View

2.
Guo J, Yao C, Chen H, Zhuang D, Tang W, Ren G . The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas. Acta Neurochir (Wien). 2012; 154(8):1361-70. PMC: 3407558. DOI: 10.1007/s00701-012-1418-x. View

3.
Hess K, Broglio K, Bondy M . Adult glioma incidence trends in the United States, 1977-2000. Cancer. 2004; 101(10):2293-9. DOI: 10.1002/cncr.20621. View

4.
Haegler K, Wiesmann M, Bohm C, Freiherr J, Schnell O, Bruckmann H . New similarity search based glioma grading. Neuroradiology. 2011; 54(8):829-37. DOI: 10.1007/s00234-011-0988-2. View

5.
Brant-Zawadzki M, Berry I, Osaki L, Brasch R, Murovic J, Norman D . Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions. AJR Am J Roentgenol. 1986; 147(6):1223-30. DOI: 10.2214/ajr.147.6.1223. View